AI Isomorphic inks deals with Eli Lilly and Novartis for drug discovery

AI

Редактор
Регистрация
23 Август 2023
Сообщения
2 818
Лучшие ответы
0
Реакции
0
Баллы
51
Offline
#1
Isomorphic Labs, the London-based, drug discovery-focused spin-out of Google AI R&D division DeepMind, today announced that it’s entered into strategic partnerships with two pharmaceutical giants, Eli Lilly and Novartis, to apply AI to discover new medications to treat challenging diseases. The deals have a combined value of around $3 billion. Isomorphic will receive $45 million […]

© 2023 TechCrunch. All rights reserved. For personal use only.
 
Сверху Снизу